Tags

Type your tag names separated by a space and hit enter

[Intermittent fasting : A solution for metabolic disorders?]
Rev Med Suisse. 2021 Jan 13; 17(720-1):59-62.RM

Abstract

The management of obesity comprises lifestyle changes targeting nutrient content, eating behavior and regular physical activity. Medication (orlistat, liraglutide) and bariatric surgery can later be used, but they require a clear indication and a close follow-up. Studies in chronobiology are now exploring the metabolic benefits of intermittent fasting, which restricts food intake and calorie-containing beverages to a certain window of the 24h cycle, or to certain days of the week/month, thus reinstating the alternance between anabolism and catabolism. However, the current scientific evidence is limited by the sample size and duration of the studies. It is therefore too early for a blanket strategy based on intermittent fasting in all patients with metabolic disorders.

Authors+Show Affiliations

Service d'endocrinologie, diabétologie, nutrition et éducation thérapeutique du patient, Département de médecine, HUG, 1211 Genève 14.Service d'endocrinologie, diabétologie, nutrition et éducation thérapeutique du patient, Département de médecine, HUG, 1211 Genève 14.

Pub Type(s)

Journal Article
Review

Language

fre

PubMed ID

33443833

Citation

Collet, Tinh-Hai, and Zoltan Pataky. "[Intermittent Fasting : a Solution for Metabolic Disorders?]." Revue Medicale Suisse, vol. 17, no. 720-1, 2021, pp. 59-62.
Collet TH, Pataky Z. [Intermittent fasting : A solution for metabolic disorders?]. Rev Med Suisse. 2021;17(720-1):59-62.
Collet, T. H., & Pataky, Z. (2021). [Intermittent fasting : A solution for metabolic disorders?]. Revue Medicale Suisse, 17(720-1), 59-62.
Collet TH, Pataky Z. [Intermittent Fasting : a Solution for Metabolic Disorders?]. Rev Med Suisse. 2021 Jan 13;17(720-1):59-62. PubMed PMID: 33443833.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Intermittent fasting : A solution for metabolic disorders?] AU - Collet,Tinh-Hai, AU - Pataky,Zoltan, PY - 2021/1/14/entrez PY - 2021/1/15/pubmed PY - 2021/1/30/medline SP - 59 EP - 62 JF - Revue medicale suisse JO - Rev Med Suisse VL - 17 IS - 720-1 N2 - The management of obesity comprises lifestyle changes targeting nutrient content, eating behavior and regular physical activity. Medication (orlistat, liraglutide) and bariatric surgery can later be used, but they require a clear indication and a close follow-up. Studies in chronobiology are now exploring the metabolic benefits of intermittent fasting, which restricts food intake and calorie-containing beverages to a certain window of the 24h cycle, or to certain days of the week/month, thus reinstating the alternance between anabolism and catabolism. However, the current scientific evidence is limited by the sample size and duration of the studies. It is therefore too early for a blanket strategy based on intermittent fasting in all patients with metabolic disorders. SN - 1660-9379 UR - https://www.unboundmedicine.com/medline/citation/33443833/[Intermittent_fasting_:_A_solution_for_metabolic_disorders] L2 - https://medlineplus.gov/metabolicdisorders.html DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.